slide deck (pdf) - CME Outfitters

More documents

Recommendations

Info

Clinical Management Step 4: Referral For the patient with symptoms and bother who is refractory to therapy ! Alpha blockers, PDE5is, antimuscarinics and β3 agonists work quickly. ! 5 ARIs work slowly ! Failure to respond in a reasonable amount of time warrants reevaluation and possible referral Rosenberg MT, et al. Int J Clin Pract. 2010; 64(4):488-496. PMID: 20039975. Rosenberg MT, et al. Publication Pending.
Clinical Connections: Summary ! Treatment of LUTS-BPH should be a patient-centered, shared decision process ! There appears to be a shared pathophysiology that underlies benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) ! Pharmacotherapy of BPH-LUTS and ED takes place in a stepwise algorithm that depends on symptom severity. ! Diagnosis and treatment plans in accordance with the American Urological Association recommendations can improve the management of patients with BPH and ED
Page 1 and 2:
Gaining Ground in Men’s Genitouri
Page 3 and 4:
Accreditation This program has been
Page 5 and 6:
Learning Objectives ! Explain the s
Page 7 and 8:
Matt T. Rosenberg, MD Disclosures S
Page 9 and 10:
Disclosures ! Faculty of this CE ac
Page 11 and 12:
Get Social with Us CMEOutfitters.co
Page 13 and 14:
Georgia Association of Physician As
Page 15 and 16:
Matt T. Rosenberg, MD Disclosures S
Page 17 and 18: In what percentage of your patients
Page 19 and 20: Function of the Prostate Normal Fun
Page 21 and 22: Benign Prostatic Hyperplasia ! A co
Page 23 and 24: Predominant Symptoms ! The enlarged
Page 25 and 26: Definition of OAB International Con
Page 27 and 28: How to differentiate the etiology o
Page 29 and 30: Common Comorbidities in BPH-LUTS Co
Page 31 and 32: Audience Response Question Fact: ED
Page 33 and 34: BPH-LUTS and ED Common Pathophysiol
Page 35 and 36: What to Keep in Mind in the Evaluat
Page 37 and 38: The Evaluation of LUTS: History, Ph
Page 39 and 40: Medications Can Cause or Exacerbate
Page 41 and 42: Laboratory Tests ! Urinalysis ! Inf
Page 43 and 44: Audience Response Question The most
Page 45 and 46: The Purpose of the Voiding Diary !
Page 47 and 48: Rosenberg MT, et al. Publication Pe
Page 49 and 50: STEP 1: Informed Surveillance If th
Page 51 and 52: Clinical Management Step2a: Alpha B
Page 53 and 54: Clinical Management Step2b: Phospho
Page 55 and 56: Rosenberg MT, et al. Publication Pe
Page 57 and 58: Antimuscarinics - Immediate Release
Page 59 and 60: ! Dry Mouth ! Constipation ! Headac
Page 61 and 62: Beta 3 Agonists Drug Mirabegron Dos
Page 63 and 64: Clinical Management Step3b: Adding
Page 65 and 66: 5 Alpha Reductase Inhibitors (5ARI)
Page 67: Rosenberg MT, et al. Publication Pe
show all

slide deck (pdf) - CME Outfitters

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?